A study conducted in The Netherlands showed that nearly 45% of patients with bladder cancer had pathologic upstaging after radical cystectomy. Discrepancies between clinical and pathologic staging of ...
Treatment recommendations for all stages of bladder cancer have been proposed in the form of clinical guidelines from the European Association of Urology and the American Urological Association.
Patients requiring intraoperative conversion from robotic-assisted radical cystectomy to open surgery have higher 90-day mortality rates and 30-day readmission rates. Intraoperative conversion from ...
Extended oral antibiotic prophylaxis eliminated UTIs after robot-assisted radical cystectomy procedures. Prophylactic antibiotics reduced overall infections by two-thirds and saved $9,000 per patient.
A 30-day course of prophylactic antibiotics following robot-assisted radical cystectomy significantly reduces the incidence of urinary tract infections (UTIs) and related complications, researchers ...
Radical cystectomy involves bladder removal and urinary diversion, often using a laparoscopic robot-assisted approach for precision and access. The surgery lasts four to six hours, with a recovery ...
—A retrospective real-world study of patients with muscle-invasive bladder cancer showed that robot-assisted and laparoscopic radical cystectomy reduce post-surgical complication rates, compared to ...
First survival outcomes and biomarker results of SURE-01: Neoadjuvant sacituzumab govitecan (SG) monotherapy, followed by radical cystectomy (RC), in patients with muscle-invasive urothelial bladder ...
In a recent conversation with CURE, Hensley discussed the current treatment landscape of non-muscle-invasive bladder cancer, as well as how patient counseling is guided by individual risk factors.
Investigators searched for predictors of insensitivity to neoadjuvant cisplatin-based chemotherapy among patients with muscle-invasive bladder cancer.